Immunoblot analysis For detection of Gclc (Santa Cruz Biotechnology sc-390811), Pdha-1 (Abcam ab168379), DRP1 (Abcam ab184247), eIF4E (Abcam ab33766), p-eIF4E (Abcam ab76256), 4E-BP1 (Cell signaling 9452), p-4E-BP1 (Cell signaling 2855), DRP1 (Abcam ab184247), mTOR (Cell Signaling 2972), p-mTOR (Ser2448) (Cell Signaling 2971), p70 S6 (Cell Signaling 9202), p-p70 S6 (Thr421/Ser424) (Cell Signaling 9204), 15 10 6 cells were lysed with lysis buffer (CST 9803S) and protein/phosphatases inhibitors as per manufacturers protocol and blotted as described 44
6 Abilify was also approved in 2009 for use in children aged 6 and up with autism
Consistent use for 812 weeks is recommended
The average age of konzo affected children was 9.25 2.2 years with samples taken from 59 konzo affected Male siblings and 43 konzo affected Female Siblings
Studies show that PEA can be used as an anti-inflammatory to help relieve chronic pain